Skip to main content
All lobbying filings

MYRIAD GENETICS, INC.

Lobbying for MYRIAD GENETICS, INC.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $260,000.00 expenses · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Medicare/Medicaid

Prior authorization issues in Medicare Advantage.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem